PAQR6
Membrane progestin receptor delta
Also known as: FLJ22672, PAQR6_HUMAN, PRdelta
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6TCH4
- Gene
- PAQR6
- Ensembl
- ENSG00000160781
- Chromosome
- 1
- Canonical length
- 344 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins
- Quaternary structure
- Homodimer
OverviewNCBI Gene
Predicted to enable signaling receptor activity. Predicted to be located in plasma membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
344 residues, UniProt reviewed canonical sequence.
>Q6TCH4|PAQR6
1 MLSLKLPQLL QVHQVPRVFW EDGIMSGYRR PTSSALDCVL SSFQMTNETV NIWTHFLPTW
61 YFLWRLLALA GGPGFRAEPY HWPLLVFLLP ACLYPFASCC AHTFSSMSPR MRHICYFLDY
121 GALSLYSLGC AFPYAAYSMP ASWLHGHLHQ FFVPAAALNS FLCTGLSCYS RFLELESPGL
181 SKVLRTGAFA YPFLFDNLPL FYRLGLCWGR GHGCGQEALS TSHGYHLFCA LLTGFLFASH
241 LPERLAPGRF DYIGHSHQLF HICAVLGTHF QLEAVLADMG SRRAWLATQE PALGLAGTVA
301 TLVLAAAGNL LIIAAFTATL LRAPSTCPLL QGGPLEGGTQ AKQQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PAQR6 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 7
- Mean surface accessibility (rSASA)
- 0.27
- Highest tissue expression
- 912 nTPM
Expression across tissuesHPA
Tissue
- spinal cord: 912 nTPM
- midbrain: 609 nTPM
- hippocampal formation: 309 nTPM
- amygdala: 279 nTPM
- hypothalamus: 274 nTPM
- basal ganglia: 242 nTPM
Single-cell type
- oligodendrocytes: 65 nCPM
- astrocytes: 56 nCPM
- müller glia: 53 nCPM
- bergmann glia: 50 nCPM
- schwann cells: 25 nCPM
- ependymal cells: 22 nCPM
Immune cell
- NK-cell: 5.7 nTPM
- MAIT T-cell: 0.8 nTPM
- plasmacytoid DC: 0.6 nTPM
- memory CD4 T-cell: 0.4 nTPM
- memory B-cell: 0.3 nTPM
- gdT-cell: 0.2 nTPM
Brain region
- medulla oblongata: 482 nTPM
- pons: 445 nTPM
- white matter: 398 nTPM
- spinal cord: 392 nTPM
- midbrain: 296 nTPM
- thalamus: 281 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.52
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.75
- DepMap mean gene effect
- -0.25
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PAQR6 as an antibody target. Whether an autoantibody or antibody against PAQR6 could matter depends on whether native PAQR6 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PAQR6 is annotated at the cell surface, where native PAQR6 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label PAQR6 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...